Clinical Trials Directory

Trials / Completed

CompletedNCT06242288

Correlation Between Depression Scores and Serum NF-ĸB/NLRP3 Axis, Biotinidase, and HMGB After Treatment With Isotretinoin in Patients With Acne Vulgaris

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Mostafa Bahaa · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Acne is a chronic inflammatory disease of the pilosebaceous unit resulting from androgen-induced increased sebum production, altered keratinization, inflammation, and bacterial colonization of hair follicles on the face, neck, chest, and back by, Cutibacterium acnes. Although all age groups can be affected, it is primarily a disease of adolescence. Treatment selection is based on disease severity, patient preference, and tolerability. Isotretinoin is drug of chioce used for moderate and severe acne. Isotretinoin results in a significant reduction in sebum production, influences comedogenesis, lowers surface and ductal c. acnes and has anti-inflammatory properties. Biotin deficiency may be caused by insufficient dietary uptake of biotin, drug- vitamin interactions and increased biotin catabolism during pregnancy and in smokers. Biotin deficiency can also be precipitated by decreased activities of biotinidase, which plays a central role in the intestinal absorption of biotin

Conditions

Interventions

TypeNameDescription
DRUGISOtretinoin 20 MGIsotretinoin, also known as 13-cis-retinoic acid and sold under the brand name Accutane among others, is a medication primarily used to treat severe acne

Timeline

Start date
2024-01-30
Primary completion
2025-01-20
Completion
2025-01-20
First posted
2024-02-05
Last updated
2025-03-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06242288. Inclusion in this directory is not an endorsement.